Bazedoxifene is a third generation selective estrogen receptor modulator (SERM). Bazedoxifene is used as part of the combination drug DUAVEE in the prevention of postmenopausal osteoporosis. Bazedoxifene has been approved by the U.S Food and Drug Administration on October 3, 2013.
Product Name: Bazedoxifene
CAS Number: 198481-32-2
Molecular Weight:  470.6102
Molecular Formula:  C30H34N2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.